5-Phenyl-1,3,4-Dioxazol-2-Yl 2,3,4,6-Tetra-O-Acetyl-T1-Thio-D-Glucopyranoside

Zz Qiu,Pf Xu

DOI: https://doi.org/10.1107/S1600536804014734

2004-01-01

Abstract:The crystal structure of the title compound, C-22H24N2O10S, has been determined by X-ray diffraction. The molecule contains a sugar ring and a planar substituted heterocyclic ring linked, unusually, by an S atom. The sugar ring is in the normal chair conformation.

What problem does this paper attempt to address?

2-Acetylamino-1,3,4,6-tetra-o-(trimethylsilyl)-2-deoxy-α-d-glucopyranose

Zhao-Dong Cheng,Yan-Li Cui,Jian-Wei Mao

DOI: https://doi.org/10.1107/s160053681301266x

2013-01-01

Acta Crystallographica Section E Structure Reports Online

Abstract:The title compound, C20H47NO6Si4, was synthesized by per-O-trimethylsilylation of N-acetyl-d-glucosamine using chlorotrimethylsilane in the presence of hexamethyldisiloxane. The trimethylsilyl group and acetamido group are located on the same side of the pyran ring, showing an α-configuration glycoside. One of the trimethylsilyl groups is disordered over two orientations, with site-occupancy factors of 0.625 (9) and 0.375 (9). In the crystal, N—H⋯O hydrogen bonds link the molecules into supramolecular chains along the a-axis direction.
2-Acetyl-amino-1,3,4,6-tetra-O-(tri-methyl-silyl)-2-de-oxy-α-d-gluco-pyran-ose.

Zhao-Dong Cheng,Yan-Li Cui,Jian-Wei Mao

DOI: https://doi.org/10.1107/S160053681301266X

2013-01-01

Abstract:The title compound, C20H47NO6Si4, was synthesized by per-O-tri-methyl-silylation of N-acetyl-d-glucosa-mine using chloro-tri-methyl-silane in the presence of hexa-methyl-disiloxane. The tri-methyl-silyl group and acetamido group are located on the same side of the pyran ring, showing an α-configuration glycoside. One of the tri-methyl-silyl groups is disordered over two orientations, with site-occupancy factors of 0.625 (9) and 0.375 (9). In the crystal, N-H⋯O hydrogen bonds link the mol-ecules into supra-molecular chains along the a-axis direction.
Crystal Structure of 2-(1-benzyl-3-phenyl-1h-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S

Xu-Wen Huang,Jin-Zong You,Wan-Min Ni,Yi-Ping Zhang,Qi Feng,Wen-Chang Xu,Sheng-Yue Tong,Tang-Qi Li,De-Qiang Qi

DOI: https://doi.org/10.1515/ncrs-2016-0262

2017-01-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C25H19N5O3S, monoclinic, P21/c (no. 14), a = 16.715(2) Å, b = 11.2677(15) Å, c = 12.6490(17) Å, β = 110.818(2)°, V = 2226.7(5) Å3, Z = 4, Rgt(F) = 0.0424, wRref(F2) = 0.1037, T = 296 K.
Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

chao wu,yanjun guo,xiaolong zhang,aibao xia

DOI: https://doi.org/10.1080/15421406.2014.928446

IF: 0.7

2015-01-01

Molecular Crystals and Liquid Crystals

Abstract:The title compound, (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one, was synthesized and characterized by H-1 and C-13 NMR and HRMS spectroscopy. Its absolute molecular configuration was investigated by X-ray crystallography. The crystal structure analysis revealed that the structure exhibits intermolecular hydrogen bonds of the type O-H horizontal ellipsis O. The methyl group and chlorophenyl group are located in the cis configuration. The conformation is stabilized by weak intermolecular C-H... O interactions.
1-Phenylethyl Phenyldithioacetate

Jing Gao,Yingwu Luo,Bogeng Li

DOI: https://doi.org/10.1107/s1600536806017624

2006-01-01

Abstract:The overall shape of the title compound, C16H16S2, is like a capital 'M', with both planar benzene rings projecting to one side of the central thioacetate portion.
3,4-Dicyanophenyl 2,3,4,6-Tetra-o-acetyl-α-d-glucopyranoside

Yuejing Bin,Fuqun Zhao,Fushi Zhang,Ru-Ji Wang

DOI: https://doi.org/10.1107/s1600536807049860

2007-01-01

Abstract:The title compound, C(22)H(22)N(2)O(10), was prepared by the glycosidation method through nitrite displacement on substituted nitro-phthalonitrile. The mol-ecule contains a benzene ring, two nitrile groups and an acetyl-protected d-glucose fragment which adopts a chair conformation. The absolute configuration was determined by the use of d-glucose as starting material. All substituents of the protected sugar are in equatorial positions, with the exclusive presence of the α-anomer. The crystal packing is stabilized by C-H⋯O and C-H⋯N hydrogen-bonding inter-actions.
3,4-Dicyanophenyl 2,3,4,6-tetra-O-acetyl-α-<scp>D</scp>-glucopyranoside

Yuejing Bin,Fuqun Zhao,Fushi Zhang,Ru-Ji Wang

DOI: https://doi.org/10.1107/S1600536807049860

2007-01-01

Abstract:The title compound, C22H22N2O10, was prepared by the glycosidation method through nitrite displacement on substituted nitrophthalonitrile. The molecule contains a benzene ring, two nitrile groups and an acetyl-protected d-glucose fragment which adopts a chair conformation. The absolute configuration was determined by the use of d-glucose as starting material. All substituents of the protected sugar are in equatorial positions, with the exclusive presence of the α-anomer. The crystal packing is stabilized by C—H...O and C—H...N hydrogen-bonding interactions.
Crystal Structure of Ethyl 1-Benzyl-5-phenyl-1h-pyrazole-3-carboxylate, C19h18n2o2

Wen-Chang Xu,Jin-Zong You,Qi Feng,Yi-Ping Zhang,Wan-Min Ni,Xu-Wen Huang,Tang-Qi Li,Sheng-Yue Tong,De-Qiang Qi

DOI: https://doi.org/10.1515/ncrs-2016-0261

2017-01-01

Abstract:C19H18N2O2, triclinic, P1̅ (no. 2), a = 9.832(2) Å, b = 10.590(2) Å, c = 17.794(3) Å, α = 77.080(3)°, β = 81.720(4)°, γ = 64.958(3)°, V = 1633.7(5) Å3, Z = 4, Rgt(F) = 0.0634, wRref(F2) = 0.1964, T = 296 K.
(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

Yongzhou Hu,Huazhou Ying

DOI: https://doi.org/10.1107/S1600536805001807

2005-01-01

Abstract:The title compound, C27H24Cl3N3O7S, contains a thiadiazoline ring which is almost planar. The two ethoxy groups bonded at the 3a- and 4-positions are in a trans configuration.
(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

Yong-Zhou Hu,Hua-Zhou Ying

DOI: https://doi.org/10.1107/s1600536805001807

2005-01-01

Abstract:The title compound, C27H24Cl3N3O7S, contains a thiadiazoline ring which is almost planar. The two ethoxy groups bonded at the 3a- and 4-positions are in a trans configuration.
(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitrophenyl)‐4‐(4‐chlorophenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thiadiazoline

Yongzhou Hu,Huazhou Ying

DOI: https://doi.org/10.1107/s1600536805001807

2005-01-01

Abstract:The title compound, C27H24Cl3N3O7S, contains a thiadiazoline ring which is almost planar. The two ethoxy groups bonded at the 3a- and 4-positions are in a trans configuration.
Ethyl (4aR*,7S*,8S*,8aS*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1H-isochromene-8-carboxylate

Xiu Qing Jiang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536810017009

2010-01-01

Abstract:In the title compound, C18H20O4, both the tetrahydropyranone ring and the cyclohexene ring adopt envelope conformations. The crystal packing is stabilized by weak intermolecular C—H⋯O hydrogen bonding.
Methyl 7-(4-bromophenyl)-5-methyl-4,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carbo Xylate

Chang-Sheng Yao,Chen-Xia Yu,Song Lei,Shu-Jiang Tu

DOI: https://doi.org/10.1107/s160053680703824x

2007-01-01

Abstract:The title compound, C13H12BrN5O2, was obtained by the solid-state reaction of 4-bromobenzaldehyde, 1H-tetrazol-5amine hydrate and methyl acetoacetate catalysed by sulfamic acid. The pyrimidine ring adopts a flattened boat conformation. In the crystal structure, centrosymmetrically related molecules are linked into dimers by intermolecular N - H center dot center dot center dot N hydrogen bonds.
Ethyl (4ar*,7s*,8s*,8as*)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

Xiu Qing Jiang,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536810017009

2010-01-01

Abstract:In the title compound, C(18)H(20)O(4), both the tetrahydropyran-one ring and the cyclohexene ring adopt envelope conformations. The crystal packing is stabilized by weak intermolecular C-H center dot center dot center dot O hydrogen bonding.
(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

Hao Shi,Hong Xiang Sun

DOI: https://doi.org/10.1107/s1600536808043341

2008-01-01

Abstract:The title compound, C24H32O8S center dot C3H6O, features three six-membered and two five-membered rings. The six-membered rings adopt chair, boat and slightly distorted boat conformations whereas one five-membered ring adopts an approximate envelope conformation and the other a twist conformation. Disorder was modelled for the ethylthio group with the ethyl-C atoms resolved over three positions with occupancies of 0.58 (4), 0.23 (4) and 0.19 (3). In the crystal, an O-H center dot center dot center dot O hydrogen bond links the molecules into chains.
Ethyl 1-phenyl-3-sulfanyl-5-(4H-1,2,4-triazol-4-yl)pyrazole-4-carboxylate

Wei-Qiang Chen,Miao Du,Lin-Hong Weng,Gui-Yu Jin

DOI: https://doi.org/10.1107/s1600536801010091

2001-01-01

Abstract:In the crystal structure of the title compound, C15H15N5O2S, the triazole ring forms a π56 configuration in which the N between the two C atoms is sp2 hybridized. A strong S⋯S(−x, −y, −z) interaction exists between adjacent molecules producing a zigzag line along the c axis with an S⋯S distance of 3.123 (3) A, and a three-dimensional network is formed through C—H⋯N and C—H⋯O hydrogen bonds.
2,3,4-Tri-o-acetyl-β-d-xylosyl 2,4-Dichloro-phenoxy-acetate.

Xiaoming Wang,Xinyuan Li,Yale Yin,Yanjun Pang,Yonghua Yang

DOI: https://doi.org/10.1107/s1600536808005837

2008-01-01

Abstract:In the title compound, C(19)H(20)Cl(2)O(10), the hexopyranosyl ring adopts a chair conformation. The four substituents are in equatorial positions. The mol-ecules arelinked via C-H⋯O contacts along the a axis.
6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

JX Xu,S Jin,ZY Zhang,TCW Mak

DOI: https://doi.org/10.1107/s0108270198005630

1998-01-01

Acta Crystallographica Section C Crystal Structure Communications

Abstract:The title compound, C31H24ClNO2S, has a cis-ring-fusion tricyclic structure, which is formed from a benzene ring, a seven-membered heterocyclic thiazepine ring and a 1,3-oxazinone ring. The 1,5-thiazepine ring has a slightly distorted boat-like conformation, whereas the 1,3-oxazinone ring adopts a half-chair conformation.
2,3,4,6-Tetra-o-acetyl-1-o-(4-methoxy-cinnamo-yl)-β-d-glucopyran-ose.

Yuan-Yuan Liu,Shan Liu,Qing-Yan Chu,Hong-Jun Zhu

DOI: https://doi.org/10.1107/s1600536808004698

2008-01-01

Abstract:Mol-ecules of the title compound, C(24)H(28)O(12), are linked by inter-molecular C-H⋯O hydrogen bonds. Bond lengths and angles are normal.
4-(O-methoxyphenyl)-1,3,4,4a,5,6,7,8a-octahydro-2h-pyrano[2,3-d]pyrimidine-2-thione

Lei Yan,Yulin Zhu,Yuan-jiang Pan

DOI: https://doi.org/10.1107/s1600536805010068

2005-01-01

Abstract:The title compound, C14H18N2O2S, which was obtained from an extended Biginelli reaction, contains a pyran ring with a chair conformation, a pyrimidine ring with a half-chair conformation and a benzene ring. The crystal structure is stabilized by an intermolecular hydrogen-bond network.

5-Phenyl-1,3,4-Dioxazol-2-Yl 2,3,4,6-Tetra-O-Acetyl-T1-Thio-D-Glucopyranoside

2-Acetylamino-1,3,4,6-tetra-o-(trimethylsilyl)-2-deoxy-α-d-glucopyranose

2-Acetyl-amino-1,3,4,6-tetra-O-(tri-methyl-silyl)-2-de-oxy-α-d-gluco-pyran-ose.

Crystal Structure of 2-(1-benzyl-3-phenyl-1h-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

1-Phenylethyl Phenyldithioacetate

3,4-Dicyanophenyl 2,3,4,6-Tetra-o-acetyl-α-d-glucopyranoside

3,4-Dicyanophenyl 2,3,4,6-tetra-<i>O</i>-acetyl-α-<scp>D</scp>-glucopyranoside

Crystal Structure of Ethyl 1-Benzyl-5-phenyl-1h-pyrazole-3-carboxylate, C19h18n2o2

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitrophenyl)‐4‐(4‐chlorophenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thiadiazoline

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

Methyl 7-(4-bromophenyl)-5-methyl-4,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carbo Xylate

Ethyl (4ar,7s,8s,8as)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

Ethyl 1-phenyl-3-sulfanyl-5-(4<i>H</i>-1,2,4-triazol-4-yl)pyrazole-4-carboxylate

2,3,4-Tri-o-acetyl-β-d-xylosyl 2,4-Dichloro-phenoxy-acetate.

6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

2,3,4,6-Tetra-o-acetyl-1-o-(4-methoxy-cinnamo-yl)-β-d-glucopyran-ose.

4-(O-methoxyphenyl)-1,3,4,4a,5,6,7,8a-octahydro-2h-pyrano[2,3-d]pyrimidine-2-thione

5-Phenyl-1,3,4-Dioxazol-2-Yl 2,3,4,6-Tetra-O-Acetyl-T1-Thio-D-Glucopyranoside

2-Acetylamino-1,3,4,6-tetra-o-(trimethylsilyl)-2-deoxy-α-d-glucopyranose

2-Acetyl-amino-1,3,4,6-tetra-O-(tri-methyl-silyl)-2-de-oxy-α-d-gluco-pyran-ose.

Crystal Structure of 2-(1-benzyl-3-phenyl-1h-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

1-Phenylethyl Phenyldithioacetate

3,4-Dicyanophenyl 2,3,4,6-Tetra-o-acetyl-α-d-glucopyranoside

3,4-Dicyanophenyl 2,3,4,6-tetra-<i>O</i>-acetyl-α-<scp>D</scp>-glucopyranoside

Crystal Structure of Ethyl 1-Benzyl-5-phenyl-1h-pyrazole-3-carboxylate, C19h18n2o2

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitro­phenyl)‐4‐(4‐chloro­phenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thia­diazo­line

Ethyl (4a<i>R</i>*,7<i>S</i>*,8<i>S</i>*,8a<i>S</i>*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

Methyl 7-(4-bromophenyl)-5-methyl-4,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carbo Xylate

Ethyl (4ar*,7s*,8s*,8as*)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

Ethyl 1-phenyl-3-sulfanyl-5-(4<i>H</i>-1,2,4-triazol-4-yl)pyrazole-4-carboxylate

2,3,4-Tri-o-acetyl-β-d-xylosyl 2,4-Dichloro-phenoxy-acetate.

6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

2,3,4,6-Tetra-o-acetyl-1-o-(4-methoxy-cinnamo-yl)-β-d-glucopyran-ose.

4-(O-methoxy­phenyl)-1,3,4,4a,5,6,7,8a-octa­hydro-2h-pyrano­[2,3-d]­pyrimidine-2-thione

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitrophenyl)‐4‐(4‐chlorophenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thiadiazoline

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

Ethyl (4ar,7s,8s,8as)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

4-(O-methoxyphenyl)-1,3,4,4a,5,6,7,8a-octahydro-2h-pyrano[2,3-d]pyrimidine-2-thione